Acute Kidney Disease and Clinical Outcomes in Stable Outpatients With Decompensated Cirrhosis: A Prospective Cohort Study.
Abstract
Background/Aims Acute kidney disease (AKD), as recently redefined by the Acute Disease Quality Initiative-International Club of Ascites (ADQI-ICA) consensus, captures persistent or subacute kidney dysfunction often following acute kidney injury (AKI). Its prognostic relevance in stable outpatients with decompensated cirrhosis remains insufficiently characterized. This study aimed to evaluate the associations of AKD and its phenotypes (AKI-AKD and non-AKI AKD [NAKI-AKD]) with cirrhosis-related complications and mortality in outpatients with stable decompensated cirrhosis. Methods In this prospective real-world study, 131 patients were followed for up to 60 mo. AKD was defined according to ADQI-ICA criteria and modeled as a time-dependent exposure. Complications were analyzed using Poisson incidence rate and cause-specific Cox models. Mortality was assessed using Aalen-Johansen estimates and time-dependent cause-specific Cox regression, with liver transplantation considered a competing event and parsimonious adjustment for baseline liver disease severity. Results AKD developed in 51 patients (38.9%). The overall complication-event rate was higher following AKD onset than during AKD-free follow-up (183.3 vs 36.6 per 100 person-years; adjusted incidence rate ratio: 4.91, 95% confidence interval [CI]: 3.01-8.03; P < 0.001). In the MELD 3.0-adjusted model, the mortality hazard was highest during the AKD period (0-90 d after onset [adjusted cause-specific hazard ratio (aCsHR): 27.07, 95% CI: 11.83-61.90; P < 0.001]) and remained elevated during the late follow-up after AKD (aCsHR: 8.77, 95% CI: 4.00-19.23; P < 0.001). Among patients with AKD, AKI-AKD was associated with higher mortality than NAKI-AKD (aCsHR: 3.07, 95% CI: 1.46-6.47; P = 0.003). Conclusion AKD is common among stable outpatients with decompensated cirrhosis and was associated with a graded risk of complications and death. Phenotypic stratification identifies AKI-AKD as the highest-risk subgroup, although these findings require confirmation in larger prospective studies.